A PPARγ antagonist III
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

G3335

Item No. 17593

Technical Information
Formal Name
L-tryptophyl-L-glutamic acid
CAS Number
36099-95-3
Molecular Formula
C16H19N3O5
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 1 mg/mlDMSO: 5 mg/mlPBS (pH 7.2): 1 mg/ml
λmax
218, 278, 288 nm
SMILES
OC(CC[C@@H](C(O)=O)NC([C@@H](N)CC1=CNC2=C1C=CC=C2)=O)=O
InChi Code
InChI=1S/C16H19N3O5/c17-11(7-9-8-18-12-4-2-1-3-10(9)12)15(22)19-13(16(23)24)5-6-14(20)21/h1-4,8,11,13,18H,5-7,17H2,(H,19,22)(H,20,21)(H,23,24)/t11-,13-/m0/s1
InChi Key
PWIQCLSQVQBOQV-AAEUAGOBSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    G3335 is a cell-permeable dipeptide that potently antagonizes PPARγ (Kd = 8.34 µM).1 It reversibly and competitively blocks activation of PPARγ by rosiglitazone (IC50 = 8-32 µM).1 G3335 is active in vivo, abolishing the protective effects of rosiglitazone in experimental spinal cord injury in rats.2 G3335 has also been used to evaluate the role of PPARγ in neurotoxicity studies.3,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ye, F., Zhang, Z.S., Luo, H.B., et alThe dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARγ: Bioassay with molecular modeling simulation. Chembiochem 7, 74-82 (2006).

    2. Meng, Q.Q., Liang, X.J., Wang, P., et alRosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury. Neurosci. Lett. 503, 191-195 (2011).

    3. Di Cesare Mannelli, L., Zanardelli, M., Micheli, L., et alPPAR-γ impairment alters peroxisome functionality in primary astrocyte cell cultures. Biomed Res. Int. 2014, 1-12 (2014).

    4. Zanardelli, M., Micheli, L., Cinci, L., et alOxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach. PLoS One 9(7), 1-15 (2014).